An Infernal Trio: The chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology

Annals of Anatomy

Volumn 195, Issue 2, 2013, Pages 103-110

  Hattermann, Kirsten ^a   Mentlein, Rolf ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Chemokine receptors; Chemokines; Gliomas; Signaling; Tumor biology

Indexed keywords

BETA ARRESTIN; BETA DEFENSIN 3; CCX 662; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CXCL11 CHEMOKINE; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 1BETA; INTESTINAL TREFOIL FACTOR; JANUS KINASE 2; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLERIXAFOR; PROTEIN KINASE B; SCATTER FACTOR; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; TEMOZOLOMIDE; TREFOIL FACTOR 2; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; BREAST CANCER; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXTRAVASATION; GLIOBLASTOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTERNALIZATION; LUNG CANCER; NONHUMAN; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR GROWTH;

ANIMALS; BRAIN NEOPLASMS; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, CXCR; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION;

EID: 84876707038     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2012.10.013     Document Type: Review

References (114)

1. Adler M.W., Geller E.B., Chen X., Rogers T.J. Viewing chemokines as a third major system of communication in the brain. AAPS J. 2005, 7:E865-E870.
2. Aiuti A., Webb I.J., Bleul C., Springer T., Gutierrez-Ramos J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 1997, 185:111-120.
3. Ajami K., Pitman M.R., Wilson C.H., Park J., Menz R.I., Starr A.E., Cox J.H., Abbott C.A., Overall C.M., Gorrell M.D. Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8. FEBS Lett. 2008, 582:819-825.
4. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
5. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., Arenzana-Seisdedos F., Thelen M., Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 2005, 280:35760-35766.
6. Barbero S., Bonavia R., Bajetto A., Porcile C., Pirani P., Ravetti J.L., Zona G.L., Spaziante R., Florio T., Schettini G. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 2003, 63:1969-1974.
7. Barlic J., Khandaker M.H., Mahon E., Andrews J., DeVries M.E., Mitchell G.B., Rahimpour R., Tan C.M., Ferguson S.S., Kelvin D.J. Beta-arrestins regulate interleukin-8-induced CXCR1 internalization. J. Biol. Chem. 1999, 274:16287-16294.
8. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S.R., Bucala R., Hickey M.J., Weber C. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 2007, 13:587-596.
9. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-833.
10. Brand S., Dambacher J., Beigel F., Olszak T., Diebold J., Otte J.M., Goke B., Eichhorst S.T. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp. Cell Res. 2005, 310:117-130.
11. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., Penfold M.E., Sunshine M.J., Littman D.R., Kuo C.J., Wei K., McMaster B.E., Wright K., Howard M.C., Schall T.J. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 2006, 203:2201-2213.
12. Canals M., Scholten D.J., de Munnik S., Han M.K., Smit M.J., Leurs R. Ubiquitination of CXCR7 controls receptor trafficking. PLoS ONE 2012, 7:e34192.
13. Clatot F., Picquenot J.M., Choussy O., Gouerant S., Moldovan C., Schultheis D., Cornic M., Francois A., Blot E., Laberge-Le-Couteulx S. Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma. Oral Oncol. 2011, 47:1062-1068.
14. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., Lin W., Boyd J.G., Moser B., Wood D.E., Sahagan B.G., Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 1998, 187:2009-2021.
15. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
16. De La Luz Sierra M., Yang F., Narazaki M., Salvucci O., Davis D., Yarchoan R., Zhang H.H., Fales H., Tosato G. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 2004, 103:2452-2459.
17. Decaillot F.M., Kazmi M.A., Lin Y., Ray-Saha S., Sakmar T.P., Sachdev P. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J. Biol. Chem. 2011, 286:32188-32197.
18. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
19. Drury L.J., Ziarek J.J., Gravel S., Veldkamp C.T., Takekoshi T., Hwang S.T., Heveker N., Volkman B.F., Dwinell M.B. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17655-17660.
20. Dubeykovskaya Z., Dubeykovskiy A., Solal-Cohen J., Wang T.C. Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines. J. Biol. Chem. 2009, 284:3650-3662.
21. Dubrovska A., Elliott J., Salamone R.J., Telegeev G.D., Stakhovsky A.E., Schepotin I.B., Yan F., Wang Y., Bouchez L.C., Kularatne S.A., Watson J., Trussell C., Reddy V.A., Cho C.Y., Schultz P.G. CXCR4 expression in prostate cancer progenitor cells. PLoS ONE 2012, 7:e31226.
22. Ebisawa M., Yamada T., Bickel C., Klunk D., Schleimer R.P. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J. Immunol. 1994, 153:2153-2160.
23. Ehtesham M., Mapara K.Y., Stevenson C.B., Thompson R.C. CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett. 2009, 274:305-312.
24. Esencay M., Newcomb E.W., Zagzag D. HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration. J. Neurooncol. 2010, 99:33-40.
25. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
26. Feng Z., Dubyak G.R., Lederman M.M., Weinberg A. Cutting edge: human beta defensin 3-a novel antagonist of the HIV-1 coreceptor CXCR4. J. Immunol. 2006, 177:782-786.
27. Fernandis A.Z., Prasad A., Band H., Klosel R., Ganju R.K. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004, 23:157-167.
28. Gassmann P., Haier J., Schluter K., Domikowsky B., Wendel C., Wiesner U., Kubitza R., Engers R., Schneider S.W., Homey B., Muller A. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia 2009, 11:651-661.
29. Geminder H., Sagi-Assif O., Goldberg L., Meshel T., Rechavi G., Witz I.P., Ben-Baruch A. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J. Immunol. 2001, 167:4747-4757.
30. Gupta S.K., Lysko P.G., Pillarisetti K., Ohlstein E., Stadel J.M. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 1998, 273:4282-4287.
31. Han Y., He T., Huang D.R., Pardo C.A., Ransohoff R.M. TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J. Clin. Invest. 2001, 108:425-435.
32. Hao M., Zheng J., Hou K., Wang J., Chen X., Lu X., Bo J., Xu C., Shen K. Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem. Pharmacol. 2012, 84:204-214.
33. Haribabu B., Richardson R.M., Fisher I., Sozzani S., Peiper S.C., Horuk R., Ali H., Snyderman R. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J. Biol. Chem. 1997, 272:28726-28731.
34. Hartmann T.N., Burger J.A., Glodek A., Fujii N., Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 2005, 24:4462-4471.
35. Hattermann K., Ludwig A., Gieselmann V., Held-Feindt J., Mentlein R. The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. Mol. Cell. Neurosci. 2008, 39:133-141.
36. Hattermann K., Held-Feindt J., Lucius R., Muerkoster S.S., Penfold M.E., Schall T.J., Mentlein R. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res. 2010, 70:3299-3308.
37. Hattermann K., Mentlein R., Held-Feindt J. CXCL12 mediates apoptosis resistance in rat C6 glioma cells. Oncol. Rep. 2012, 27:1348-1352.
38. Heinrich E.L., Lee W., Lu J., Lowy A.M., Kim J. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J. Transl. Med. 2012, 10:68.
39. Hong X., Jiang F., Kalkanis S.N., Zhang Z.G., Zhang X.P., DeCarvalho A.C., Katakowski M., Bobbitt K., Mikkelsen T., Chopp M. SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett. 2006, 236:39-45.
40. Iwasa S., Yanagawa T., Fan J., Katoh R. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res. 2009, 29:4751-4758.
41. Joo E.K., Broxmeyer H.E., Kwon H.J., Kang H.B., Kim J.S., Lim J.S., Choe Y.K., Choe I.S., Myung P.K., Lee Y. Enhancement of cell survival by stromal cell-derived factor-1/CXCL12 involves activation of CREB and induction of Mcl-1 and c-Fos in factor-dependent human cell line MO7e. Stem Cells Dev. 2004, 13:563-570.
42. Kasahara T., Mukaida N., Yamashita K., Yagisawa H., Akahoshi T., Matsushima K. IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 1991, 74:60-67.
43. Keeley E.C., Mehrad B., Strieter R.M. Chemokines as mediators of tumor angiogenesis and neovascularization. Exp. Cell Res. 2011, 317:685-690.
44. Kijima T., Maulik G., Ma P.C., Tibaldi E.V., Turner R.E., Rollins B., Sattler M., Johnson B.E., Salgia R. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res. 2002, 62:6304-6311.
45. Koshiba T., Hosotani R., Miyamoto Y., Ida J., Tsuji S., Nakajima S., Kawaguchi M., Kobayashi H., Doi R., Hori T., Fujii N., Imamura M. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res. 2000, 6:3530-3535.
46. Kumar R., Tripathi V., Ahmad M., Nath N., Mir R.A., Chauhan S.S., Luthra K. CXCR7 mediated Gialpha independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells. Cell Immunol. 2012, 272:230-241.
47. Lechertier T., Berard M., Vassy R., Herve M.A., Crepin M. Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes. Anticancer Res. 2004, 24:4011-4017.
48. Levoye A., Balabanian K., Baleux F., Bachelerie F., Lagane B. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009, 113:6085-6093.
49. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
50. Liang Z., Brooks J., Willard M., Liang K., Yoon Y., Kang S., Shim H. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem. Biophys. Res. Commun. 2007, 359:716-722.
51. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 1994, 269:232-237.
52. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114:97-109.
53. Ludwig A., Schiemann F., Mentlein R., Lindner B., Brandt E. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J. Leukoc. Biol. 2002, 72:183-191.
54. Luker K.E., Gupta M., Luker G.D. Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J. 2009, 23:823-834.
55. Luker K.E., Steele J.M., Mihalko L.A., Ray P., Luker G.D. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 2010, 29:4599-4610.
56. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., Bronson R.T., Springer T.A. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9448-9453.
57. Majka M., Ratajczak J., Kowalska M.A., Ratajczak M.Z. Binding of stromal derived factor-1alpha (SDF-1alpha) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK). ELK-1 transcription factor and serine/threonine kinase AKT. Eur. J. Haematol. 2000, 64:164-172.
58. Marchese A., Benovic J.L. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J. Biol. Chem. 2001, 276:45509-45512.
59. Marechal R., Demetter P., Nagy N., Berton A., Decaestecker C., Polus M., Closset J., Deviere J., Salmon I., Van Laethem J.L. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br. J. Cancer 2009, 100:1444-1451.
60. Matsuo Y., Ochi N., Sawai H., Yasuda A., Takahashi H., Funahashi H., Takeyama H., Tong Z., Guha S. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int. J. Cancer 2009, 124:853-861.
61. Matsusue R., Kubo H., Hisamori S., Okoshi K., Takagi H., Hida K., Nakano K., Itami A., Kawada K., Nagayama S., Sakai Y. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann. Surg. Oncol. 2009, 16:2645-2653.
62. Miao Z., Luker K.E., Summers B.C., Berahovich R., Bhojani M.S., Rehemtulla A., Kleer C.G., Essner J.J., Nasevicius A., Luker G.D., Howard M.C., Schall T.J. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:15735-15740.
63. Miekus K., Jarocha D., Trzyna E., Majka M. Role of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines. Folia Histochem. Cytobiol. 2010, 48:104-111.
64. Miyanishi N., Suzuki Y., Simizu S., Kuwabara Y., Banno K., Umezawa K. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion. Biochem. Biophys. Res. Commun. 2010, 403:154-159.
65. Mizokami Y., Kajiyama H., Shibata K., Ino K., Kikkawa F., Mizutani S. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma. Int. J. Cancer 2004, 110:652-659.
66. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
67. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., Miller L.H., Oppenheim J.J., Power C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000, 52:145-176.
68. Nagasawa T., Kikutani H., Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2305-2309.
69. Narumi S., Hamilton T.A. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J. Immunol. 1991, 146:3038-3044.
70. Naumann U., Cameroni E., Pruenster M., Mahabaleshwar H., Raz E., Zerwes H.G., Rot A., Thelen M. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS ONE 2010, 5:e9175.
71. ödemis V., Boosmann K., Heinen A., Kury P., Engele J. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J. Cell Sci. 2010, 123:1081-1088.
72. ödemis V., Lipfert J., Kraft R., Hajek P., Abraham G., Hattermann K., Mentlein R., Engele J. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells. Glia 2012, 60:372-381.
73. Oh J.W., Drabik K., Kutsch O., Choi C., Tousson A., Benveniste E.N. CXC chemokine receptor 4 expression and function in human astroglioma cells. J. Immunol. 2001, 166:2695-2704.
74. O'Hayre M., Salanga C.L., Handel T.M., Allen S.J. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem. J. 2008, 409:635-649.
75. Orsini M.J., Parent J.L., Mundell S.J., Marchese A., Benovic J.L. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the C-terminal tail that mediate receptor internalization. J. Biol. Chem. 1999, 274:31076-31086.
76. Padovani-Claudio D.A., Liu L., Ransohoff R.M., Miller R.H. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2. Glia 2006, 54:471-483.
77. Paget S. The distribution of secondary grwoths in cancer of the breast. Lancet 1889, 133:571-573.
78. Ping Y.F., Yao X.H., Jiang J.Y., Zhao L.T., Yu S.C., Jiang T., Lin M.C., Chen J.H., Wang B., Zhang R., Cui Y.H., Qian C., Wang J., Bian X.W. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J. Pathol. 2011, 224:344-354.
79. Rajagopal S., Kim J., Ahn S., Craig S., Lam C.M., Gerard N.P., Gerard C., Lefkowitz R.J. Beta-arrestin - but not G protein-mediated signaling by the " decoy" receptor CXCR7. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:628-632.
80. Reiss K., Mentlein R., Sievers J., Hartmann D. Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience 2002, 115:295-305.
81. Rempel S.A., Dudas S., Ge S., Gutierrez J.A. Identification and localization of the cytokine SDF1 and its receptor. CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin. Cancer Res. 2000, 6:102-111.
82. Rollins B.J. Chemokines. Blood 1997, 90:909-928.
83. Rostene W., Dansereau M.A., Godefroy D., Van Steenwinckel J., Reaux-Le Goazigo A., Melik-Parsadaniantz S., Apartis E., Hunot S., Beaudet N., Sarret P. Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J. Neurochem. 2011, 118:680-694.
84. Rubin J.B., Kung A.L., Klein R.S., Chan J.A., Sun Y., Schmidt K., Kieran M.W., Luster A.D., Segal R.A. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13513-13518.
85. Saini V., Marchese A., Majetschak M. CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. J. Biol. Chem. 2010, 285:15566-15576.
86. Saini V., Staren D.M., Ziarek J.J., Nashaat Z.N., Campbell E.M., Volkman B.F., Marchese A., Majetschak M. The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1alpha function through distinct receptor interactions. J. Biol. Chem. 2011, 286:33466-33477.
87. Schanz A., Winn V.D., Fisher S.J., Blumenstein M., Heiss C., Hess A.P., Kruessel J.S., McMaster M., North R.A. Pre-eclampsia is associated with elevated CXCL12 levels in placental syncytiotrophoblasts and maternal blood. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 157:32-37.
88. + channel activity. Am. J. Physiol. Cell Physiol. 2010, 299:C175-C184.
89. Shioda T., Kato H., Ohnishi Y., Tashiro K., Ikegawa M., Nakayama E.E., Hu H., Kato A., Sakai Y., Liu H., Honjo T., Nomoto A., Iwamoto A., Morimoto C., Nagai Y. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6331-6336.
90. Signoret N., Oldridge J., Pelchen-Matthews A., Klasse P.J., Tran T., Brass L.F., Rosenkilde M.M., Schwartz T.W., Holmes W., Dallas W., Luther M.A., Wells T.N., Hoxie J.A., Marsh M. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 1997, 139:651-664.
91. Singh S., Srivastava S.K., Bhardwaj A., Owen L.B., Singh A.P. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. Br. J. Cancer 2010, 103:1671-1679.
92. Smith W.B., Gamble J.R., Clark-Lewis I., Vadas M.A. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991, 72:65-72.
93. Strieter R.M., Burdick M.D., Gomperts B.N., Belperio J.A., Keane M.P. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 2005, 16:593-609.
94. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996.
95. Sun Y.X., Wang J., Shelburne C.E., Lopatin D.E., Chinnaiyan A.M., Rubin M.A., Pienta K.J., Taichman R.S. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J. Cell. Biochem. 2003, 89:462-473.
96. Sun Y.X., Schneider A., Jung Y., Wang J., Dai J., Cook K., Osman N.I., Koh-Paige A.J., Shim H., Pienta K.J., Keller E.T., McCauley L.K., Taichman R.S. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J. Bone Miner. Res. 2005, 20:318-329.
97. Tachibana K., Hirota S., Iizasa H., Yoshida H., Kawabata K., Kataoka Y., Kitamura Y., Matsushima K., Yoshida N., Nishikawa S., Kishimoto T., Nagasawa T. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393:591-594.
98. Taichman R.S., Cooper C., Keller E.T., Pienta K.J., Taichman N.S., McCauley L.K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002, 62:1832-1837.
99. Takabatake Y., Sugiyama T., Kohara H., Matsusaka T., Kurihara H., Koni P.A., Nagasawa Y., Hamano T., Matsui I., Kawada N., Imai E., Nagasawa T., Rakugi H., Isaka Y. The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J. Am. Soc. Nephrol. 2009, 20:1714-1723.
100. Tan C.T., Chu C.Y., Lu Y.C., Chang C.C., Lin B.R., Wu H.H., Liu H.L., Cha S.T., Prakash E., Ko J.Y., Kuo M.L. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis 2008, 29:1519-1527.
101. Tang C.H., Tan T.W., Fu W.M., Yang R.S. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 2008, 29:35-43.
102. Todaro M., Alea M.P., Di Stefano A.B., Cammareri P., Vermeulen L., Iovino F., Tripodo C., Russo A., Gulotta G., Medema J.P., Stassi G. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1:389-402.
103. Uchimura K., Morimoto-Tomita M., Bistrup A., Li J., Lyon M., Gallagher J., Werb Z., Rosen S.D. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem. 2006, 7:2.
104. van Golen K.L., Ying C., Sequeira L., Dubyk C.W., Reisenberger T., Chinnaiyan A.M., Pienta K.J., Loberg R.D. CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac. J. Cell. Biochem. 2008, 104:1587-1597.
105. Vandercappellen J., Van Damme J., Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008, 267:226-244.
106. Veldkamp C.T., Peterson F.C., Pelzek A.J., Volkman B.F. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci. 2005, 14:1071-1081.
107. Wang J., Shiozawa Y., Wang Y., Jung Y., Pienta K.J., Mehra R., Loberg R., Taichman R.S. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J. Biol. Chem. 2008, 283:4283-4294.
108. Yang S.X., Chen J.H., Jiang X.F., Wang Q.L., Chen Z.Q., Zhao W., Feng Y.H., Xin R., Shi J.Q., Bian X.W. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 2005, 335:523-528.
109. Yoshie O., Imai T., Nomiyama H. Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol. 1997, 62:634-644.
110. Zabel B.A., Lewen S., Berahovich R.D., Jaen J.C., Schall T.J. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol. Cancer 2011, 10:73.
111. Zagzag D., Lukyanov Y., Lan L., Ali M.A., Esencay M., Mendez O., Yee H., Voura E.B., Newcomb E.W. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab. Invest. 2006, 86:1221-1232.
112. Zannettino A.C., Farrugia A.N., Kortesidis A., Manavis J., To L.B., Martin S.K., Diamond P., Tamamura H., Lapidot T., Fujii N., Gronthos S. Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Cancer Res. 2005, 65:1700-1709.
113. Zhang J., Sarkar S., Yong V.W. The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 2005, 26:2069-2077.
114. Zhang R., Pan X., Huang Z., Weber G.F., Zhang G. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS ONE 2011, 6:e23831.